Global Systemic Lupus Erythematosus (SLE) Drugs Market, Size, Share & Forecast to 2019

1
Top 10 Diabetes Care Technologies, Devices and
Therapeutics Markets - Growth, Global Share,
Industry Overview, Analysis, Trends Opportunities
and Forecast 2012 - 2020
Global Systemic Lupus Erythematosus (SLE) Drugs
Market 2015-2019 Growth, Global Share, Industry
Overview, Analysis, Trends Opportunities and
Forecast
2
Description
Report Overview
About SLE SLE is the most common form of lupus
and is also called lupus. It is a chronic,
autoimmune disease with signs and symptoms that
can last for six months or for many years. It can
affect any part of the body, such as the skin,
joints, and organs (LFA, 2012). SLE occurs when
the immune system produces autoantibodies, which
attack and destroy healthy tissues in the body
rather than foreign infectious agents. These
autoantibodies cause inflammation, pain, and
damage. It is also known as a disease of
flare-ups and remissions and can range from mild
to life threatening in severity. No cure for SLE
yet exists.   The Global SLE Drugs market to
grow at a CAGR of 22.41 percent over the period
2014-2019.   Read more details at
http//www.bigmarketresearch.com/global-systemic-l
upus-erythematosus-sle-drugs-2015-2019-market
3
Key Benefits
Summery
Covered in this Report This report covers the
present scenario and the growth prospects of the
Global SLE Drugs market for the period 2015-2019.
To calculate the market size, the report
considers revenue generated from the sales of
various drugs used in the treatment of SLE that
are available in the market.   The Global SLE
Drugs Market 2015-2019, has been prepared based
on an in-depth market analysis with inputs from
industry experts. The report covers the Americas,
and the APAC and EMEA it covers the Global SLE
Drugs market landscape and its growth prospects
in the coming years. The report includes a
discussion of the key vendors operating in this
market.
4
Key Audiences
Key Regions Americas APAC EMEA
  Key Vendors Anthera Pharmaceuticals BMS
GSK ImmuPharma Merck Serono UCB  
5
Table Of Contents
Key Audiences

• Other Prominent Vendors
• Amgen
• HGS
• Immunomedics
• Johnson and Johnson
• MedImmune
• Sanofi
• Teva Pharmaceutical Industries

6
Table Of Contents
Company Profile
Market Driver High Prevalence of Autoimmune
Disease For a full, detailed list, view our
report   Market Challenge Complex Etiology
For a full, detailed list, view our
report   Market Trend Increase in Awareness
For a full, detailed list, view our report
7
Table Of Contents
Key Questions Answered in this Report What will
the market size be in 2019 and what will the
growth rate be? What are the key market
trends? What is driving this market? What are
the challenges to market growth? Who are the
key vendors in this market space? What are the
market opportunities and threats faced by the key
vendors? What are the strengths and weaknesses
of the key vendors?   Enquire about report
http//www.bigmarketresearch.com/report-enquiry/22
2329
8
Get Full Information At http//www.bigmarketrese
arch.com/global-systemic-lupus-erythematosus-sle-d
rugs-2015-2019-market